Mark Agulnik, MD

Professor of Clinical Medicine

Vice Chair for Faculty Development, Department of Medicine

Section Chief of Sarcomas & Melanoma

Image of Mark Agulnik, MD
Is this your profile? Click to edit

Publications

  • Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trial. Nat Med. 2026 Jun; 32(6):2191-2200.. View in PubMed
  • Metabolic profile alterations as early indicators of gastrointestinal stromal tumors (GISTs) recurrence and imatinib resistance. J Gastrointest Oncol. 2026 Jun 30; 17(3):139.. View in PubMed
  • Liver Transplantation After Prolonged Nab-Sirolimus Therapy for Unresectable Hepatic Perivascular Epithelioid Cell Tumor With Bilobar Involvement. ACG Case Rep J. 2026 Apr; 13(4):e02095.. View in PubMed
  • Rate and Type of Surgery and Prevalence of Malignancy in Patients With Ollier’s Disease and Maffucci Syndrome. Am J Med Genet A. 2026 Sep; 200(9):2025-2035.. View in PubMed
  • Tazemetostat, an EZH2 inhibitor, in solid tumors harboring SWI/SNF alterations: a phase II basket study. Nat Commun. 2026 Mar 25; 17(1).. View in PubMed
  • Management of tenosynovial giant cell tumor: approved and investigational therapies. Expert Rev Anticancer Ther. 2026 Jul; 26(7):881-889.. View in PubMed
  • Cabozantinib and temozolomide in patients with unresectable or metastatic leiomyosarcoma and other soft tissue sarcomas: a multicentre, single-arm, lead-in phase 2 trial. Lancet Oncol. 2026 Feb; 27(2):223-232.. View in PubMed
  • Chondrosarcoma: Clinical behavior, molecular mechanisms, and emerging therapeutic strategies. Crit Rev Oncol Hematol. 2026 Feb; 218:105075.. View in PubMed
  • Sarcoma: Cardiovascular and Oncologic Considerations: JACC: CardioOncology State-of-the-Art Review. JACC CardioOncol. 2025 Dec; 7(7):800-815.. View in PubMed
  • Response to Letter to the Editor From Zhang et al: “Cabozantinib Plus Ipilimumab/Nivolumab in Patients with Previously Treated Advanced Differentiated Thyroid Cancer”. J Clin Endocrinol Metab. 2025 Jun 17; 110(7):e2425-e2426.. View in PubMed